Lysis of staphylococcal mastitis pathogens by bacteriophage phi11 endolysin

FEMS Microbiology Letters

Volumn 265, Issue 1, 2006, Pages 133-139

  Donovan, David M ^a   Lardeo, Michelle ^a   Foster Frey, Juli ^a  

^a AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

Antimicrobial; Coagulase negative staphylococcus; Peptidoglycan hydrolase; Phi11 endolysin; Staphylococcus aureus

Indexed keywords

AMIDASE; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; CALCIUM; HYDROLASE; PEPTIDOGLYCAN; PHI11 ENDOLYSIN; PROTEINASE; UNCLASSIFIED DRUG;

ACIDITY; ARTICLE; BACTERIAL CELL WALL; BACTERIAL VIRULENCE; BACTERIOLYSIS; BACTERIOPHAGE; BINDING SITE; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; MASTITIS; MILK; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PURIFICATION; REDUCTION KINETICS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HYICUS; STAPHYLOCOCCUS SIMULANS; STAPHYLOCOCCUS XYLOSUS; TURBIDITY;

ANIMALS; CALCIUM; CATTLE; ENDOPEPTIDASES; HYDROGEN-ION CONCENTRATION; MASTITIS, BOVINE; MILK; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS PHAGES;

STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HYICUS; STAPHYLOCOCCUS SIMULANS; STAPHYLOCOCCUS WARNERI; STAPHYLOCOCCUS XYLOSUS;

EID: 33750839781     PISSN: 03781097     EISSN: 15746968     Source Type: Journal    
DOI: 10.1111/j.1574-6968.2006.00483.x     Document Type: Article

References (45)

1. Baba T & Schneewind O (1998) Targeting of muralytic enzymes to the cell division site of Gram-positive bacteria: repeat domains direct autolysin to the equatorial surface ring of Staphylococcus aureus. EMBO J 17: 4639-4646.
2. Bateman A & Rawlings ND (2003) The CHAP domain: a large family of amidases including GSP amidase and peptidoglycan hydrolases. Trends Biochem Sci 28: 234-237.
3. Browder HP, Zygmunt WA, Young JR & Travormina PA (1965) Lysostaphin: ezymatic mode of action. Biochem Bio Phys Res Commun 19: 383-389.
4. Cattell MB, Dinsmore RP, Belschner AP, Carmen J & Goodell G (2001) Environmental gram-positive mastitis treatment: in vitro sensitivity and bacteriologic cure. J Dairy Sci 84: 2036-2043.
5. Cheng Q, Nelson D, Zhu S & Fischetti VA (2005) Removal of group B streptococci colonizing the vagina and oropharynx of mice with a bacteriophage lytic enzyme. Antimicrob Agents Chemother 49: 111-117.
6. Deluyker HA, Van Oye SN & Boucher JF (2005) Factors affecting cure and somatic cell count after pirlimycin treatment of subclinical mastitis in lactating cows. J Dairy Sci 88: 604-614.
7. De Oliveira AP, Watts JL, Salmon SA & Aarestrup FM (2000) Antimicrobial susceptibility of Staphylococcus aureus isolated from bovine mastitis in Europe and the United States. J Dairy Sci 83: 855-862.
8. Diaz E, Lopez R & Garcia JL (1990) Chimeric phage-bacterial enzymes: a clue to the modular evolution of genes. Proc Natl Acad Sci USA 87: 8125-8129.
9. Donovan DM, Kerr DE & Wall RJ (2005) Engineering disease resistant cattle. Transgenic Res 14: 563-567.
10. Donovan DM, Foster-Frey JA, Dong S, Rousseau G, Moineau S & Pritchard DG (2006) The cell lysis activity of the Streptococcus agalactiae bacteriophage B30 endolysin relies on the CHAP endopeptidase domain. Appl Environ Microbiol 72: 5108-5112.
11. Donovan DM, Dong S, Garrett W, Rousseau G, Moineau S & Pritchard DG (2006) Peptidoglycan hydrolase fusions maintain their parental specificities. Appl Environ Microbiol 72: 2988-2996.
12. Erskine RJ, Walker RD, Bolin CA, Bartlett PC & White DG (2002) Trends in antibacterial susceptibility of mastitis pathogens during a seven-year period. J Dairy Sci 85: 1111-1118.
13. Ferber D (2002) Antibiotic resistance. Livestock feed ban preserves drugs' power. Science 295: 27-28.
14. Ferber D (2003) Antibiotic resistance. WHO advises kicking the livestock antibiotic habit. Science 301: 1027.
15. Fischetti VA (2003) Novel method to control pathogenic bacteria on human mucous membranes. Ann N Y Acad Sci 987: 207-214.
16. Fischetti VA (2005) Bacteriophage lytic enzymes: novel anti-infectives. Trends Microbiol 13: 491-496.
17. Garcia P, Garcia JL, Garcia E, Sanchez-Puelles JM & Lopez R (1990) Modular organization of the lytic enzymes of Streptococcus pneumoniae and its bacteriophages. Gene 86: 81-88.
18. Huard C, Miranda G, Wessner F, Bolotin A, Hansen J, Foster SJ & Chapot-Chartier MP (2003) Characterization of AcmB, an N-acetylglucosaminidase autolysin from Lactococcus lactis. Microbiology 149: 695-705.
19. Jado I, Lopez R, Garcia E, Fenoll A, Casal J, Garcia P & Spanish Pneumococcal Infection Study Network. (2003) Phage lytic enzymes as therapy for antibiotic-resistant Streptococcus pneumoniae infection in a murine sepsis model. J Antimicrob Chemother 52: 967-973.
20. Jayaswal RK, Lee YI & Wilkinson BJ (1990) Cloning and expression of a Staphylococcus aureus gene encoding a peptidoglycan hydrolase activity. J Bacteriol 172: 5783-5788.
21. Kerr DE & Wellnitz O (2003) Mammary expression of new genes to combat mastitis. J Anim Sci 81: (Suppl 3): 38-47.
22. Kerr DE, Plaut K, Bramley AJ, Williamson CM, Lax AJ, Moore K, Wells KD &Wall RJ (2001) Lysostaphin expression in mammary glands confers protection against staphylococcal infection in transgenic mice. Nat Biotechnol 19: 66-70.
23. Kwan T, Liu J, DuBow M, Gros P & Pelletier J (2005) The complete genomes and proteomes of 27 Staphylococcus aureus bacteriophages. Proc Natl Acad Sci USA 102: 5174-5179.
24. Loeffler JM, Nelson D & Fischetti VA (2001) Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase. Science 294: 2170-2172.
25. Loessner MJ (2005) Bacteriophage endolysins-current state of research and applications. Curr Opin Microbiol 8: 480-487.
26. Lopez R & Garcia E (2004) Recent trends on the molecular biology of pneumococcal capsules, lytic enzymes, and bacteriophage. FEMS Microbiol Rev 28: 553-580.
27. Morita M, Tanji Y, Orito Y, Mizoguchi K, Soejima A & Unno H (2001) Functional analysis of antibacterial activity of Bacillus amyloliquefaciens phage endolysin against Gram-negative bacteria. FEBS Lett 500: 56-59.
28. Nathan C (2004) http://www.nature.com/news/2004/041018/pf/431899a_pf.html
29. Navarre WW, Ton-That H, Faull KF & Schneewind O (1999) Multiple enzymatic activities of the murein hydrolase from staphylococcal phage phi11. Identification of a D-alanyl-glycine endopeptidase activity. J Biol Chem 274: 15847-15856.
30. Nelson D, Loomis L & Fischetti VA (2001) Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzyme. Proc Natl Acad Sci USA 98: 4107-4712.
31. Neville MC, Keller RP, Casey C & Allen JC (1994) Calcium partitioning in Human and bovine Milk. J Dairy Sci 77: 1964-1975.
32. O'Flaherty S, Coffey A, Meaney W, Fitzgerald GF & Ross RP (2005) The recombinant phage lysin LysK has a broad spectrum of lytic activity against clinically relevant staphylococci, including methicillin-resistant Staphylococcus aureus. J Bacteriol 187: 7161-7164.
33. Pritchard DG, Dong S, Baker JR & Engler JA (2004) The bifunctional peptidoglycan lysin of Streptococcus agalactiae bacteriophage B30. Microbiology 150: 2079-2087.
34. Rajala-Schultz PJ, Smith KL, Hogan JS & Love BC (2004) Antimicrobial susceptibility of mastitis pathogens from first lactation and older cows. Vet Microbiol 102: 33-42.
35. Rigden DJ, Jedrzejas MJ & Galperin MY (2003) Amidase domains from bacterial and phage autolysins define a family of gamma-D,L-glutamate-specific amidohydrolases. Trends Biochem Sci 28: 230-234.
36. Schuch R, Nelson D & Fischetti VA (2002) A bacteriolytic agent that detects and kills Bacillus anthracis. Nature 418: 884-889.
37. Sordillo LM & Streicher KL (2002) Mammary gland immunity and mastitis susceptibility. J Mammary Gland Biol Neoplasia 7: 135-146.
38. Thumm G & Götz F (1997) Studies on prolysostaphin processing and characterization of the lysostaphin immunity factor (Lif) of Staphylococcus simulans biovar staphylolyticus. Mol Microbiol 23: 1251-1265.
39. Waage S, Mork T, Roros A, Aasland D, Hunshamar A & Odegaard SA (1999) Bacteria associated with clinical mastitis in dairy heifers. J Dairy Sci 82: 712-719.
40. Wall RJ, Powell AM, Paape MJ, Kerr DE, Bannerman DD, Pursel VG, Wells KD, Talbot NC & Hawk HW (2005) Genetically enhanced cows resist intramammary Staphylococcus aureus infection. Nat Biotechnol 23: 445-451.
41. Walsh C (2003) Where will new antibiotics come from? Nat Rev Microbiol 1: 65-70.
42. Wang X, Wilkinson BJ & Jayaswal RK (1991) Sequence analysis of a Staphylococcus aureus gene encoding a peptidoglycan hydrolase activity. Gene 102: 105-109.
43. Werckenthin C, Cardoso M, Martel JL & Schwarz S (2001) Antimicrobial resistance in staphylococci from animals with particular reference to bovine Staphylococcus aureus, porcine Staphylococcus hyicus, and canine Staphylococcus intermedius. Vet Res 32: 341-362.
44. Wilson DJ, Gonzalez RN & Das HH (1997) Bovine mastitis pathogens in New York and Pennsylvania: prevalence and effects on somatic cell count and milk production. J Dairy Sci 80: 2592-2598.
45. Yokoi KJ, Kawahigashi N, Uchida M, Sugahara K, Shinohara M, Kawasaki K, Nakamura S, Taketo A & Kodaira K (2005) The two-component cell lysis genes holWMY and lysWMY of the Staphylococcus warneri M phage var phiWMY: cloning, sequencing, expression, and mutational analysis in Escherichia coli. Gene 351: 97-108.